IBEX Technologies Inc. appointed Joseph Zimmermann and Bruce Connop to its board.
Zimmermann succeeds Bernard Patriacca, who died. Zimmermann is president, CEO and founder of Biodextris Inc.
Connop's addition expands IBEX's board to six directors, five of whom are independent. Connop is vice president, nonclinical and pharmaceutical development, at Transition Therapeutics.
The appointments are subject to approval by the TSX Venture Exchange.